Filter
420
Filtered Results: 420
Text search:
Roche
Featured
Recommendations
46
New Publications
123
Language
Document type
No document type
250
Guidelines
64
Studies & Reports
60
Manuals
22
Fact sheets
11
Training Material
4
Strategic & Response Plan
3
Resource Platforms
2
Infographics
2
Situation Updates
1
Videos
1
Countries / Regions
Global
20
Kenya
15
Haiti
14
Senegal
11
Nigeria
9
India
9
Germany
8
Bangladesh
8
Brazil
8
Russia
8
Uganda
7
Malawi
7
Zambia
6
Tanzania
6
Western and Central Europe
6
Africa
6
Venezuela
6
Sierra Leone
5
Congo, Democratic Republic of
5
Philippines
5
Colombia
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Ghana
4
Zimbabwe
4
South Africa
4
Mozambique
4
Ukraine
4
Guinea
3
Mali
3
Ethiopia
3
Cambodia
3
Rwanda
3
Indonesia
3
Peru
3
Guinea-Bissau
2
Nepal
2
Pakistan
2
Jordan
2
Egypt
2
Syria
2
Namibia
2
Bolivia
2
Angola
2
Madagascar
2
Lesotho
2
Chile
2
West and Central Africa
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Niger
1
Togo
1
South Sudan
1
Thailand
1
Ireland
1
Sudan
1
Benin
1
Central African Republic
1
Dominican Republic
1
North Macedonia
1
Burundi
1
Honduras
1
Ecuador
1
Latin America and the Carribbean
1
Gabon
1
Uruguay
1
France
1
Authors & Publishers
Publication Years
Category
Countries
138
Clinical Guidelines
36
Public Health
21
Women & Child Health
16
Pharmacy & Technologies
13
Key Resources
9
Capacity Building
6
Toolboxes
Mental Health
49
HIV
34
TB
34
COVID-19
34
Zika
28
AMR
15
Pharmacy
14
Ebola
12
Rapid Response
12
NCDs
12
Disability
11
Planetary Health
11
Caregiver
10
NTDs
7
Refugee
6
Natural Hazards
5
Global Health Education
5
Conflict
4
Typhoon
3
Cholera
2
Social Ethics
2
Health Financing Toolbox
1
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Le cadre conceptuel scientifique pour la neutralité de la dégradation des terres (LDN) fournit une base scientifique pour comprendre, mettre en œuvre et surveiller la LDN. Il a été conçu pour créer un pont entre la vision et la mise en œuvre pratique de la NCD, en définissant la NCD en term...
Global Qualitative Nursing Research March 31, 2021 Research Article Find in PubMed
https://doi.org/10.1177/23333936211005475
Resumen ejecutivo guía de práctica clínica manejo de la infección por Sars-CoV 2
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
